First Chemical Investigation of Korean Wild Mushroom, <i>Amanita hemibapha</i> subsp. <i>javanica</i> and the Identification of Anti-<i>Helicobacter pylori</i> Compounds
<i>Amanita hemibapha</i> subsp. <i>javanica</i> (Amanitaceae) is an edible Korean wild mushroom. <i>A. hemibapha</i> subsp. <i>javanica</i> is often confused with <i>A. subjunquillea</i>, known as the East Asian death cap, which is potentia...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_c3548d4d6c1c4f6da35c5d9d4667c1a8 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Seulah Lee |e author |
700 | 1 | 0 | |a Akida Alishir |e author |
700 | 1 | 0 | |a Tae Wan Kim |e author |
700 | 1 | 0 | |a Dong-Min Kang |e author |
700 | 1 | 0 | |a Rhim Ryoo |e author |
700 | 1 | 0 | |a Changhyun Pang |e author |
700 | 1 | 0 | |a Mi-Jeong Ahn |e author |
700 | 1 | 0 | |a Ki Hyun Kim |e author |
245 | 0 | 0 | |a First Chemical Investigation of Korean Wild Mushroom, <i>Amanita hemibapha</i> subsp. <i>javanica</i> and the Identification of Anti-<i>Helicobacter pylori</i> Compounds |
260 | |b MDPI AG, |c 2022-01-01T00:00:00Z. | ||
500 | |a 10.3390/ph15020152 | ||
500 | |a 1424-8247 | ||
520 | |a <i>Amanita hemibapha</i> subsp. <i>javanica</i> (Amanitaceae) is an edible Korean wild mushroom. <i>A. hemibapha</i> subsp. <i>javanica</i> is often confused with <i>A. subjunquillea</i>, known as the East Asian death cap, which is potentially fatal when ingested. This study aimed to conduct the first chemical investigation of <i>A. hemibapha</i> subsp. <i>javanica</i>, which resulted in the isolation of seven fatty acid derivatives (<b>1</b>-<b>7</b>) and three steroids (<b>8</b>-<b>10</b>) from the MeOH extract of its fruiting bodies, and their structures were determined by comparing their NMR spectroscopic data with those previously reported, along with the data from LC/MS. Compound <b>1</b> was reported previously without the identification of its absolute configuration; its structure, including the absolute configuration was confirmed for the first time, in this study, by using <sup>1</sup>H NMR and its fragmentation patterns in MS/MS data, and LC/MS analysis. A recently developed method using competing enantioselective acylation (CEA) coupled with LC/MS analysis was applied for determining the absolute configuration of compound <b>1</b>, which revealed the 11<i>S</i>-configuration. In the anti-<i>Helicobacter pylori</i> activity test, compound <b>3</b> showed antibacterial activity against <i>H. pylori</i> strain 51 with 38.0% inhibition, comparable to that of quercetin (34.4% inhibition) as a positive control. Specifically, compound <b>4</b> displayed the most potent antibacterial activity against <i>H. pylori</i> strain 51 with 80.5% inhibition at the final concentration of 100 μm with a MIC<sub>50</sub> value of 72 μm. These findings suggested that the active compound <b>4</b> is a natural antibiotic that may be used in the development of novel antibiotics against <i>H. pylori.</i> In addition, the first chemical investigation of <i>A. hemibapha</i> subsp. <i>javanica</i> revealed that this mushroom can serve as a promising natural source for the bioactive natural products. | ||
546 | |a EN | ||
690 | |a <i>Amanita hemibapha</i> subsp. <i>javanica</i> | ||
690 | |a Amanitaceae | ||
690 | |a fatty acid derivatives | ||
690 | |a steroids | ||
690 | |a LC/MS analysis | ||
690 | |a CEA | ||
690 | |a Medicine | ||
690 | |a R | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceuticals, Vol 15, Iss 2, p 152 (2022) | |
787 | 0 | |n https://www.mdpi.com/1424-8247/15/2/152 | |
787 | 0 | |n https://doaj.org/toc/1424-8247 | |
856 | 4 | 1 | |u https://doaj.org/article/c3548d4d6c1c4f6da35c5d9d4667c1a8 |z Connect to this object online. |